Menu
Back to User profile » Dr Asuka Katsuki
Papers published by Dr Asuka Katsuki:
A single-nucleotide polymorphism influences brain morphology in drug-naïve patients with major depressive disorder
Katsuki A, Kakeda S, Watanabe K, Igata R, Otsuka Y, Kishi T, Nguyen L, Ueda I, Iwata N, Korogi Y, Yoshimura R
Neuropsychiatric Disease and Treatment 2019, 15:2425-2432
Published Date: 23 August 2019
COMT polymorphism regulates the hippocampal subfield volumes in first-episode, drug-naive patients with major depressive disorder
Otsuka Y, Kakeda S, Sugimoto K, Katsuki A, Nguyen LH, Igata R, Watanabe K, Ueda I, Kishi T, Iwata N, Korogi Y, Yoshimura R
Neuropsychiatric Disease and Treatment 2019, 15:1537-1545
Published Date: 6 June 2019
Genetic effects on white matter integrity in drug-naive patients with major depressive disorder: a diffusion tensor imaging study of 17 genetic loci associated with depressive symptoms
Kakeda S, Watanabe K, Katsuki A, Sugimoto K, Ueda I, Igata N, Kishi T, Iwata N, Abe O, Yoshimura R, Korogi Y
Neuropsychiatric Disease and Treatment 2019, 15:375-383
Published Date: 29 January 2019
Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder
Yoshimura R, Katsuki A, Atake K, Hori H, Igata R, Konishi Y
Neuropsychiatric Disease and Treatment 2017, 13:437-441
Published Date: 14 February 2017
Adding metoclopramide to paroxetine induced extrapyramidal symptoms and hyperprolactinemia in a depressed woman: a case report
Igata R, Hori H, Atake K, Katsuki A, Nakamura J
Neuropsychiatric Disease and Treatment 2016, 12:2279-2281
Published Date: 1 September 2016
Catechol-O-methyltransferase Val158Met genotype and the clinical responses to duloxetine treatment or plasma levels of 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in Japanese patients with major depressive disorder
Atake K, Yoshimura R, Hori H, Katsuki A, Nakamura J
Neuropsychiatric Disease and Treatment 2015, 11:967-974
Published Date: 3 April 2015
COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study
Hayashi K, Yoshimura R, Kakeda S, Kishi T, Abe O, Umene-Nakano W, Katsuki A, Hori H, Ikenouchi-Sugita A, Watanabe K, Ide S, Ueda I, Moriya J, Iwata N, Korogi Y, Kubicki M, Nakamura J
Neuropsychiatric Disease and Treatment 2014, 10:1183-1190
Published Date: 25 June 2014
Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone
Hori H, Yamada K, Kamada D, Shibata Y, Katsuki A, Yoshimura R, Nakamura J
Neuropsychiatric Disease and Treatment 2014, 10:527-533
Published Date: 26 March 2014